Atara Biotherapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Atara Biotherapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 6.14M shares, a 46.1% increase year-over-year.
  • Atara Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 106M shares, a 3.85% increase from 2022.
  • Atara Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 102M shares, a 8.88% increase from 2021.
  • Atara Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 93.7M shares, a 26.6% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 6.14M +1.94M +46.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 141M +36.6M +35.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 106M +3.92M +3.85% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 106M +3.98M +3.88% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 4.2M -97.4M -95.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 104M +3.24M +3.22% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 102M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 102M +8.82M +9.42% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 102M +9.45M +10.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 101M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q3 2021 93.6M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 92.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.